Flash | 14 Jul 2026 10:28:15 ET │ 11 pages Biogen Inc (BIIB.O) Diranersen phase 2 at AAIC shows promise but leaves room to prove more | Price (13 Jul 26 16:00) | US$209.03 | | --- | --- | | Target price | US$200.00 | | Expected share price return | -4.3% | | Expected dividend yield | 0.0% | | Expected total return | -4.3% | | Market Cap | US$30,861M | Geoff Meacham, Ph.D.AC +1-404-443-4701 geoffrey.meacham@citi.com Jarwei Fang +1-212-816-5127 jarwei.fang@citi.com CITI'S TAKE Full phase 2 CELIA data for dira ...